Ignite Creation Date:
2025-12-24 @ 10:50 PM
Ignite Modification Date:
2026-01-02 @ 8:00 AM
Study NCT ID:
NCT07025369
Status:
RECRUITING
Last Update Posted:
2025-09-11
First Post:
2025-06-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-08-25
Start Date Type:
ACTUAL
Primary Completion Date:
2026-07-27
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07-27
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-09
First Submit QC Date:
None
Study First Post Date:
2025-06-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-10
Last Update Post Date:
2025-09-11
Last Update Post Date Type:
ESTIMATED